Clinic and genetic predictors in response to erenumab

AbstractGenetic co-expression network (GCN) analysis augments the understanding of breast cancer (BC). We aimed to propose GCN-based modeling for BC relapse-free survival (RFS) prediction and to discover novel biomarkers. We used GCN and Cox proportional hazard regression to create various prediction models using mRNA microarray of 920 tumors and conduct external validation using independent data of 1056 tumors. GCNs of 34 identified candidate genes were plotted in various sizes. Compared to the reference model, the genetic predictors selected from bigger GCNs composed better prediction models. The prediction accuracy and AUC of 3 ~ 15-year RFS are 71.0–81.4% and 74.6–78% respectively (rfm, ACC 63.2–65.5%, AUC 61.9–74.9%). The hazard ratios of risk scores of developing relapse ranged from 1.89 ~ 3.32 (p < 10–8) over all models under the control of the node status. External validation showed the consistent finding. We found top 12 co-expressed genes are relative new or novel biomarkers that have not been explored in BC prognosis or other cancers until this decade. GCN-based modeling creates better prediction models and facilitates novel genes exploration on BC prognosis.

Download Full-text

Genetic predictors of participation in optional components of UK Biobank

Nature Communications ◽

10.1038/s41467-021-21073-y ◽

2021 ◽

Vol 12 (1) ◽

Author(s):

Jessica Tyrrell ◽

Jie Zheng ◽

Robin Beaumont ◽

Kathryn Hinton ◽

Tom G. Richardson ◽

...

Keyword(s):

Sensitivity Analysis ◽

Genetic Variants ◽

Genetic Factors ◽

Mendelian Randomization ◽

Genetic Correlations ◽

Mr Studies ◽

Uk Biobank ◽

Factors Affecting ◽

Participation Bias ◽

Genetic Predictors

AbstractLarge studies such as UK Biobank are increasingly used for GWAS and Mendelian randomization (MR) studies. However, selection into and dropout from studies may bias genetic and phenotypic associations. We examine genetic factors affecting participation in four optional components in up to 451,306 UK Biobank participants. We used GWAS to identify genetic variants associated with participation, MR to estimate effects of phenotypes on participation, and genetic correlations to compare participation bias across different studies. 32 variants were associated with participation in one of the optional components (P < 6 × 10−9), including loci with links to intelligence and Alzheimer’s disease. Genetic correlations demonstrated that participation bias was common across studies. MR showed that longer educational duration, older menarche and taller stature increased participation, whilst higher levels of adiposity, dyslipidaemia, neuroticism, Alzheimer’s and schizophrenia reduced participation. Our effect estimates can be used for sensitivity analysis to account for selective participation biases in genetic or non-genetic analyses.

Download Full-text

Do Genetic Predictors of Pain Sensitivity Associate with Persistent Widespread Pain?

Molecular Pain ◽

10.1186/1744-8069-5-56 ◽

2009 ◽

Vol 5 ◽

pp. 1744-8069-5-56 ◽

Cited By ~ 29

Author(s):

Kate L Holliday ◽

Barbara I Nicholl ◽

Gary J Macfarlane ◽

Wendy Thomson ◽

Kelly A Davies ◽

...

Keyword(s):

Pain Sensitivity ◽

Widespread Pain ◽

Genetic Predictors

Download Full-text

W06.06 Molecular-genetic Predictors of Illness Manifestation, Course, and Treatment Response

European Psychiatry ◽

10.1016/s0924-9338(00)94268-8 ◽

2000 ◽

Vol 15 (S2) ◽

pp. 290s-290s

Author(s):

W. Maier ◽

M. Ackenheil ◽

M. Rietschel ◽

T. Bayer

Keyword(s):

Treatment Response ◽

Molecular Genetic ◽

Genetic Predictors

Download Full-text